Iron-deficiency Clinical Trial
Official title:
An Absorption Study in Young Women to Evaluate the Effect of Polyphenols on Iron Absorption From Ragi (Finger Millet) Using the Iron Isotopic Method
NCT number | NCT04194567 |
Other study ID # | Ragi |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | November 4, 2019 |
Est. completion date | November 29, 2019 |
Verified date | December 2019 |
Source | Swiss Federal Institute of Technology |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In India, one of the fast growing countries, 53% of all women have anaemia as per the National Family Health Survey. A recently published study on the burden of disease in India concluded that the burden of Iron deficiency anaemia (IDA) is 3 times higher than the average globally for other geographies at a similar level of development, and that women are disproportionately affected. Finger Millet (Eleusine coracana), more commonly known as Ragi, is a type of a millet crop grown in India, is considerably rich in minerals and its micronutrient density is higher than that of the world's major cereal grains: rice and wheat. Ragi also contains different antinutrients such as phytates and polyphenols, which have been known to have an inhibiting effect on the absorption of iron. On an average, white finger millet contains 0.04-0.09% polyphenols and brown varieties have 0.08-3.47%. The dark variety of ragi is the most widely consumed type. The white ragi is the lesser consumed type. However, the levels of polyphenols, which inhibit the absorption of iron, are ten times lower in the white ragi as compared to the dark ragi. Thus, it is important to evaluate the extent of inhibition of the polyphenols on the iron absorption. This information would be beneficial for policy making and promotion of cultivation of the type of ragi that could be most effective for the consumers
Status | Completed |
Enrollment | 22 |
Est. completion date | November 29, 2019 |
Est. primary completion date | November 29, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 40 Years |
Eligibility |
Inclusion Criteria: - Female, 18 to 40 years old - Body weight up to 65 kg - Normal Body Mass Index (18.5 - 25 kg/m2) - Signed informed consent - Plasma ferritin < 25 ng/ml - Able to communicate in and comprehend English language - Tasted and found the Ragi to be of acceptable taste and confirmed will to consume the test meals if enrolled in the study Exclusion Criteria: - Pregnancy (assessed by a urinary pregnancy test) / intention to become pregnant - Lactating up to 6 weeks before study initiation - Moderate or severe anaemia (Hb < 9.0 g/dL) - Elevated CRP (> 5.0 mg/L) - Any metabolic, gastrointestinal, kidney or chronic disease such as celiac disease, diabetes, hepatitis, hypertension, cancer or cardiovascular diseases (according to the participants own statement) - Continuous/long-term use of medication during the whole study (except for contraceptives) - Consumption of mineral and vitamin supplements within 2 weeks prior to first meal administration - Blood transfusion, blood donation or significant blood loss (accident, surgery) within 4 months prior to first meal administration - Earlier participation in a study using iron stable isotopes or participation in any clinical study within the last 30 days - Participant who cannot be expected to comply with study protocol (e.g. not available on certain study appointments or difficulties with blood withdrawal) - Inability to understand the information sheet and the informed consent form due to cognitive or language reasons |
Country | Name | City | State |
---|---|---|---|
Switzerland | ETH Zurich, Laboratory of Human Nutrition | Zurich | |
Switzerland | ETH Zürich, Laboratory of Human Nutrition | Zürich | ZH |
Lead Sponsor | Collaborator |
---|---|
Swiss Federal Institute of Technology | St. John's Research Institute |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Fractional Iron absorption | The fractional iron absrption will be compared in predefined comparisons from the two interventions products that are administered to the study participants | 26th day of the study | |
Primary | Total Iron Absorption | Total iron absorption from the two ragi types will be compared by measuring the total iron absorbed from all the meals in the study | 26th day of the study | |
Secondary | Hemoglobin | Iron status marker | screening (-1), baseline (day 1), last test meal consumption (day 26) | |
Secondary | Plasma ferritin | Iron status marker | screening (-1), baseline (day 1), last test meal consumption (day 26) | |
Secondary | C-Reactive Protein | Inflammation status | screening (-1), baseline (day 1), last test meal consumption (day 26) | |
Secondary | Body Iron stores | Iron status marker | last test meal consumption (day 26) | |
Secondary | Soluble transferrin receptor | Iron status marker | last test meal consumption (day 26) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04949165 -
Bloodsafe Ghana- Iron and Nutritional Counseling Strategy Pilot Study
|
N/A | |
Terminated |
NCT03218384 -
Ferric Carboxymaltose to Improve Skeletal Muscle Metabolism in Heart Failure Patients With Functional Iron Deficiency
|
Phase 2 | |
Active, not recruiting |
NCT03516734 -
Iron-fortified Lentils to Improve Iron (Fe) Status in Bangladesh
|
N/A | |
Completed |
NCT03572010 -
Stable Iron Isotope Method in HIV+ and HIV- Children
|
N/A | |
Active, not recruiting |
NCT03703726 -
Iron Absorption From Fortified Extruded Rice Using Different Extruding Temperatures.
|
N/A | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Not yet recruiting |
NCT05395468 -
Diagnosis of Iron Deficiency by Artificial Intelligence Analysis of Eye Photography.
|
||
Withdrawn |
NCT03800446 -
Validation of a Point-of-care Device Measuring Ferritin With Capillary Blood
|
N/A | |
Not yet recruiting |
NCT03353662 -
Sub Regional Micronutrient Survey in Ethiopia
|
||
Completed |
NCT03819530 -
Child of Urban Poverty Iron Project (CUPIP) - A Pilot Study
|
N/A | |
Recruiting |
NCT04144790 -
Impact of Iron Supplementation Treatment on Brain Iron Concentrations
|
||
Completed |
NCT03957057 -
Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia
|
Phase 3 | |
Completed |
NCT03642223 -
Central and Peripheral Adiposity and Iron Absorption
|
N/A | |
Not yet recruiting |
NCT05407987 -
Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)
|
Phase 3 | |
Withdrawn |
NCT03873584 -
Improvement of Fatigue Symptoms in the Iron Deficiency Anemia With Iron Succinylate Therapy
|
||
Enrolling by invitation |
NCT03897673 -
Optimizing Benefits While Reducing Risks of Iron in Malaria-endemic Areas
|
N/A | |
Completed |
NCT04359368 -
Characteristics of Patients With Hypersensitivity Reactions to Intravenous Iron Infusions
|
||
Active, not recruiting |
NCT04778072 -
A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects
|
N/A | |
Enrolling by invitation |
NCT05750940 -
Oxidative Skeletal Muscle Metabolism in Chronic Heart Failure Patients With and Without Iron Deficiency
|
||
Recruiting |
NCT05126901 -
Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years
|
Phase 3 |